Burns: Pathophysiology of Systemic Complications and Current Management

Colton B Nielson, Nicholas C Duethman, James M Howard, Michael Moncure, John G Wood, Colton B Nielson, Nicholas C Duethman, James M Howard, Michael Moncure, John G Wood

Abstract

As a result of many years of research, the intricate cellular mechanisms of burn injury are slowly becoming clear. Yet, knowledge of these cellular mechanisms and a multitude of resulting studies have often failed to translate into improved clinical treatment for burn injuries. Perhaps the most valuable information to date is the years of clinical experience and observations in the management and treatment of patients, which has contributed to a gradual improvement in reported outcomes of mortality. This review provides a discussion of the cellular mechanisms and pathways involved in burn injury, resultant systemic effects on organ systems, current management and treatment, and potential therapies that we may see implemented in the future.

References

    1. Colohan SM. Predicting prognosis in thermal burns with associated inhalational injury: a systematic review of prognostic factors in adult burn victims. J Burn Care Res. 2010;31:529–39.
    1. Sheppard NN, Hemington-Gorse S, Shelley OP, Philp B, Dziewulski P. Prognostic scoring systems in burns: a review. Burns. 2011;37:1288–95.
    1. Hussain A, Dunn KW. Predicting length of stay in thermal burns: a systematic review of prognostic factors. Burns. 2013;39:1331–40.
    1. Bohr S, Patel SJ, Shen K, et al. Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns. Proc Natl Acad Sci U S A. 2013;110:3513–8.
    1. Schwacha MG. Macrophages and post-burn immune dysfunction. Burns. 2003;29:1–14.
    1. Vaughn L, Beckel N. Severe burn injury, burn shock, and smoke inhalation injury in small animals. Part 1: burn classification and pathophysiology. J Vet Emerg Crit Care (San Antonio) 2012;22:179–86.
    1. Ravat F, Payre J, Peslages P, Fontaine M, Sens N. Burn: an inflammatory process. Pathol Biol (Paris) 2011;59:e63–72.
    1. Sehirli O, Sener E, Sener G, Cetinel S, Erzik C, Yeğen BC. Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines. Peptides. 2008;29:1231–40.
    1. Agay D, Andriollo-Sanchez M, Claeyssen R, et al. Interleukin-6, TNF-alpha and interleukin-1 beta levels in blood and tissue in severely burned rats. Eur Cytokine Netw. 2008;19:1–7.
    1. Huang QB. Relationship between the endothelial barrier and vascular permeability after burns and its mechanism. Zhonghua Shao Shang Za Zhi. 2007;23:324–6.
    1. Wang S, Huang Q, Guo J, et al. Local thermal injury induces general endothelial cell contraction through p38 MAP kinase activation. APMIS. 2014;122:832–41.
    1. Santos FX, Arroyo C, García I, et al. Role of mast cells in the pathogenesis of postburn inflammatory response: reactive oxygen species as mast cell stimulators. Burns. 2000;26:145–7.
    1. Chu ZG, Zhang JP, Song HP, et al. p38 MAP kinase mediates burn serum-induced endothelial barrier dysfunction: involvement of F-actin rearrangement and L-caldesmon phosphorylation. Shock. 2010;34:222–8.
    1. Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns. 2008;34:6–17.
    1. Horton JW. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology. 2003;189:75–88.
    1. Zhang J, Sio SW, Moochhala S, Bhatia M. Role of hydrogen sulfide in severe burn injury-induced inflammation in mice. Mol Med. 2010;16:417–24.
    1. Fullerton JN, O’Brien AJ, Gilroy DW. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol. 2014;35:12–21.
    1. Oskeritzian CA. Mast cells and wound healing. Adv Wound Care (New Rochelle) 2012;1:23–8.
    1. Douaiher J, Succar J, Lancerotto L, et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol. 2014;122:211–52.
    1. Bankova LG, Lezcano C, Pejler G, et al. Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol. 2014;192:2812–20.
    1. Porter C, Herndon DN, Sidossis LS, Børsheim E. The impact of severe burns on skeletal muscle mitochondrial function. Burns. 2013;39:1039–47.
    1. Fagan SP, Bilodeau ML, Goverman J. Burn intensive care. Surg Clin North Am. 2014;94:765–79.
    1. Demling RH. The burn edema process: current concepts. J Burn Care Rehabil. 2005;26:207–27.
    1. Pham TN, Cancio LC, Gibran NS American Burn Association. American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res. 2008;29:257–66.
    1. Bittner EA, Shank E, Woodson L, Martyn JA. Acute and perioperative care of the burn-injured patient. Anesthesiology. 2015;122:448–64.
    1. Hosokawa S, Koseki H, Nagashima M, et al. Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate. Am J Physiol Endocrinol Metab. 2013;304:E922–33.
    1. Porter C, Herndon DN, Børsheim E, et al. Uncoupled skeletal muscle mitochondria contribute to hypermetabolism in severely burned adults. Am J Physiol Endocrinol Metab. 2014;307:E462–7.
    1. Rojas Y, Finnerty CC, Radhakrishnan RS, Herndon DN. Burns: an update on current pharmacotherapy. Expert Opin Pharmacother. 2012;13:2485–94.
    1. Zang Q, Maass DL, White J, Horton JW. Cardiac mitochondrial damage and loss of ROS defense after burn injury: the beneficial effects of antioxidant therapy. J Appl Physiol (1985) 2007;102:103–12.
    1. Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg. 2009;36:583–96.
    1. Carlson DL, Horton JW. Cardiac molecular signaling after burn trauma. J Burn Care Res. 2006;27:669–75.
    1. Willis MS, Carlson DL, Dimaio JM, et al. Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am J Physiol Heart Circ Physiol. 2005;288:H795–804.
    1. Sabry A, El-Din AB, El-Hadidy AM, Hassan M. Markers of tubular and glomerular injury in predicting acute renal injury outcome in thermal burn patients: a prospective study. Ren Fail. 2009;31:457–63.
    1. Chung KK, Stewart IJ, Gisler C, et al. The acute kidney injury network (AKIN) criteria applied in burns. J Burn Care Res. 2012;33:483–90.
    1. Mosier MJ, Pham TN, Klein MB, et al. Early acute kidney injury predicts progressive renal dysfunction and higher mortality in severely burned adults. J Burn Care Res. 2010;31:83–92.
    1. Swanson JW, Otto AM, Gibran NS, et al. Trajectories to death in patients with burn injury. J Trauma Acute Care Surg. 2013;74:282–8.
    1. You K, Yang HT, Kym D, et al. Inhalation injury in burn patients: establishing the link between diagnosis and prognosis. Burns. 2014;40:1470–5.
    1. Dries DJ. Management of burn injuries–recent developments in resuscitation, infection control and outcomes research. Scand J Trauma Resusc Emerg Med. 2009;17:14.
    1. Asmussen S, Maybauer DM, Fraser JF, et al. Extracorporeal membrane oxygenation in burn and smoke inhalation injury. Burns. 2013;39:429–35.
    1. Elsharnouby NM, Eid HE, Abou Elezz NF, Aboelatta YA. Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses. J Crit Care. 2014;29:182.e1–4.
    1. Chung KK, Rhie RY, Lundy JB, et al. A survey of mechanical ventilator practices across burn centers in North America. J Burn Care Res. 2016;37:e131–9.
    1. Vaughn L, Beckel N, Walters P. Severe burn injury, burn shock, and smoke inhalation injury in small animals. Part 2: diagnosis, therapy, complications, and prognosis. J Vet Emerg Crit Care (San Antonio) 2012;22:187–200.
    1. Song XM, Li JG, Wang YL, et al. Effect of vagus nerve stimulation on thermal injury in rats. Burns. 2010;36:75–81.
    1. Blais M, Parenteau-Bareil R, Cadau S, Berthod F. Concise review: tissue-engineered skin and nerve regeneration in burn treatment. Stem Cells Transl Med. 2013;2:545–51.
    1. Uyar IS, Onal S, Akpinar MB, et al. Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation. Cardiovasc J Afr. 2013;24:322–6.
    1. Chan Q, Ng K, Vandervord J. Critical illness polyneuropathy in patients with major burn injuries. Eplasty. 2010;10:e68.
    1. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2014;1:CD006832.
    1. Niederbichler AD, Papst S, Claassen L, et al. Burn-induced organ dysfunction: vagus nerve stimulation attenuates organ and serum cytokine levels. Burns. 2009;35:783–9.
    1. Jeschke MG. The hepatic response to thermal injury: is the liver important for postburn outcomes? Mol Med. 2009;15:337–51.
    1. Kirkpatrick AW, Ball CG, Nickerson D, D’Amours SK. Intraabdominal hypertension and the abdominal compartment syndrome in burn patients. World J Surg. 2009;33:1142–9.
    1. Malbrain ML, De Keulenaer BL, Oda J, et al. Intra-abdominal hypertension and abdominal compartment syndrome in burns, obesity, pregnancy, and general medicine. Anaesthesiol Intensive Ther. 2015;47:228–40.
    1. Burke BA, Latenser BA. Defining intra-abdominal hypertension and abdominal compartment syndrome in acute thermal injury: a multicenter survey. J Burn Care Res. 2008;29:580–4.
    1. Strang SG, Van Lieshout EM, Breederveld RS, Van Waes OJ. A systematic review on intra-abdominal pressure in severely burned patients. Burns. 2014;40:9–16.
    1. Jeschke MG, Micak RP, Finnerty CC, Herndon DN. Changes in liver function and size after a severe thermal injury. Shock. 2007;28:172–7.
    1. Greenhalgh DG. Burn resuscitation: the results of the ISBI/ABA survey. Burns. 2010;36:176–82.
    1. Williams FN, Branski LK, Jeschke MG, Herndon DN. What, how, and how much should patients with burns be fed? Surg Clin North Am. 2011;91:609–29.
    1. Rodriguez NA, Jeschke MG, Williams FN, Kamolz LP, Herndon DN. Nutrition in burns: Galveston contributions. JPEN J Parenter Enteral Nutr. 2011;35:704–14.
    1. Leclerc T, Thepenier C, Jault P, et al. Cell therapy of burns. Cell Prolif. 2011;44(suppl 1):48–54.
    1. Biesalski HK, McGregor GP. Antioxidant therapy in critical care–is the microcirculation the primary target? Crit Care Med. 2007;35(9 suppl):S577–83.
    1. Vinha PP, Martinez EZ, Vannucchi H, et al. Effect of acute thermal injury in status of serum vitamins, inflammatory markers, and oxidative stress markers: preliminary data. J Burn Care Res. 2013;34:e87–91.
    1. Sahib AS, Al-Jawad FH, Alkaisy AA. Effect of antioxidants on the incidence of wound infection in burn patients. Ann Burns Fire Disasters. 2010;23:199–205.
    1. Ghanayem H. Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 3: vitamin C in severe burns. Emerg Med J. 2012;29:1017–8.
    1. Kremer T, Harenberg P, Hernekamp F, et al. High-dose vitamin C treatment reduces capillary leakage after burn plasma transfer in rats. J Burn Care Res. 2010;31:470–9.
    1. Wolf SE. Vitamin C and smoke inhalation injury. J Burn Care Res. 2009;30:184–6.
    1. Kahn SA, Lentz CW. Fictitious hyperglycemia: point-of-care glucose measurement is inaccurate during high-dose vitamin C infusion for burn shock resuscitation. J Burn Care Res. 2015;36:e67–71.
    1. Wiggins-Dohlvik K, Han MS, Stagg HW, et al. Melatonin inhibits thermal injury-induced hyperpermeability in microvascular endothelial cells. J Trauma Acute Care Surg. 2014;77:899–905; discussion 905.
    1. Bekyarova G, Apostolova M, Kotzev I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor kappa B activation. Int J Immunopathol Pharmacol. 2012;25:591–6.
    1. Maldonado MD, Murillo-Cabezas F, Calvo JR, et al. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage. Crit Care Med. 2007;35:1177–85.
    1. Tsai ML, Huang HP, Hsu JD, et al. Topical N-acetylcysteine accelerates wound healing in vitro and in vivo via the PKC/Stat3 pathway. Int J Mol Sci. 2014;15:7563–78.
    1. Csontos C, Rezman B, Foldi V, et al. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns. 2012;38:428–37.
    1. Konukoğlu D, Cetinkale O, Bulan R. Effects of N-acetylcysteine on lung glutathione levels in rats after burn injury. Burns. 1997;23:541–4.
    1. Elijah IE, Børsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO. Role of the PPAR-α agonist fenofibrate in severe pediatric burn. Burns. 2012;38:481–6.
    1. Gauglitz GG, Williams FN, Herndon DN, Jeschke MG. Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? Curr Opin Clin Nutr Metab Care. 2011;14:176–81.
    1. Kiang JG, Zhai M, Liao PJ, Elliott TB, Gorbunov NV. Ghrelin therapy improves survival after whole-body ionizing irradiation or combined with burn or wound: amelioration of leukocytopenia, thrombocytopenia, splenomegaly, and bone marrow injury. Oxid Med Cell Longev. 2014;2014:215858.
    1. Lu G, Huang S, Chen Y, Ma K. Umbilical cord mesenchymal stem cell transplantation ameliorates burn-induced acute kidney injury in rats. Int J Low Extrem Wounds. 2013;12:205–11.
    1. Ning XH, Ge XF, Cui Y, An HX. Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways. Int Immunopharmacol. 2013;15:406–13.
    1. Finnerty CC, Herndon DN. Is propranolol of benefit in pediatric burn patients? Adv Surg. 2013;47:177–97.
    1. Park S, Karunakaran U, Jeoung NH, Jeon JH, Lee IK. Physiological effect and therapeutic application of alpha lipoic acid. Curr Med Chem. 2014;21:3636–45.
    1. Li RJ, Ji WQ, Pang JJ, Wang JL, Chen YG, Zhang Y. Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med. 2013;229:45–51.
    1. Bulmuş FG, Gürsu MF, Muz MH, Yaman I, Bulmuş O, Sakin F. Protective effects of alpha-lipoic acid on oleic acid-induced acute lung injury in rats. Balkan Med J. 2013;30:309–14.
    1. Li Y, Ma QG, Zhao LH, et al. Protective efficacy of alpha-lipoic acid against aflatoxinB1-induced oxidative damage in the liver. Asian-Australas J Anim Sci. 2014;27:907–15.
    1. Huk-Kolega H, Ciejka E, Skibska B, Kowalczyk A, Goraca A. [Influence of lipoic acid on the level of TNF-alpha in spleen homogenates]. Pol Merkur Lekarski. 2014;36:379–81.
    1. Xia X, Su C, Fu J, et al. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis. Int Immunopharmacol. 2014;22:293–302.
    1. Snell JA, Ne-Hooi WL, Tushar M, Kayvan S. Clinical review: the critical care management of the burn patient. Crit Care. 2013;17:241.
    1. Béchir M, Puhan MA, Neff SB, et al. Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury. Crit Care. 2010;14:R123.
    1. Real DS, Reis RP, Piccolo MS, Okamoto RH, Gragnani A, Ferreira LM. Oxandrolone use in adult burn patients. Systematic review and meta-analysis. Acta Cir Bras. 2014;29:68–76.
    1. Klein GL, Herndon DN, Chen TC, Holick MF. Standard multivitamin supplementation does not improve vitamin D insufficiency after burns. J Bone Miner Metab. 2009;274:502–6.
    1. Drukała J, Paczkowska E, Kucia M, et al. Stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients after skin burn injury. Stem Cell Rev. 2012;8:184–94.
    1. Clover AJ, Kumar AH, Isakson M, et al. Allogeneic mesenchymal stem cells, but not culture modified monocytes, improve burn wound healing. Burns. 2015;41:548–57.
    1. Liu P, Deng Z, Han S, et al. Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Artif Organs. 2008;32:925–31.
    1. Koljonen V, Laitila M, Rissanen AM, Sintonen H, Roine RP. Treatment of patients with severe burns-costs and health-related quality of life outcome. J Burn Care Res. 2013;34:e318–25.4.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever